Jan 7 (Reuters) -

* MAZE THERAPEUTICS INC - FILES FOR INITIAL PUBLIC OFFERING

* MAZE THERAPEUTICS, INC SAYS APPLIED TO LIST COMMON STOCK

ON

NASDAQ UNDER SYMBOL "MAZE." - SEC FILING

* MAZE THERAPEUTICS: J.P. MORGAN, TD COWEN, LEERINK

PARTNERS,

GUGGENHEIM SECURITIES ARE THE UNDERWRITERS FOR IPO

* MAZE THERAPEUTICS - ENTITIES AFFILIATED WITH THIRD ROCK

VENTURES

BENEFICIALLY OWNED 20.1% OF COMMON SHARES PRIOR TO OFFERING

* MAZE THERAPEUTICS - ENTITIES AFFILIATED WITH ARCH VENTURE

PARTNERS AND RELATED ENTITIES BENEFICIALLY OWNED 11.8% OF COMMON

SHARES PRIOR TO OFFERING

* MAZE THERAPEUTICS - ENTITIES AFFILIATED WITH GV

BENEFICIALLY

OWNED 6.9% OF COMMON SHARES PRIOR TO OFFERING

* MAZE THERAPEUTICS - MATRIX CAPITAL MANAGEMENT MASTER FUND

LP

BENEFICIALLY OWNED 7.1% OF COMMON SHARES PRIOR TO OFFERING

* MAZE THERAPEUTICS - ENTITIES AFFILIATED WITH FORESITE

CAPITAL

FUND IV LP BENEFICIALLY OWNED 6.7% OF COMMON SHARES PRIOR TO

OFFERING

Source text: